1. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD. (9th October 2018) Authors: Guiraud, Simon; Edwards, Benjamin; Squire, Sarah E; Moir, Lee; Berg, Adam; Babbs, Arran; Ramadan, Nesrine; Wood, Matthew J; Davies, Kay E Journal: Human molecular genetics Issue: Volume 28:Number 2(2019) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic. Issue 1 (7th November 2022) Authors: Conefrey, Carmel; Ochieng, Cynthia; Hoffman, Christin; Elliott, Daisy; Avery, Kerry; Bennett, Joanne; Blencowe, Natalie; Duff, Sarah; Kinross, James; McNair, Angus; Messenger, David; Pullybank, Anne; Singh, Baljit; King, Anni; Squire, Sarah E; Blazeby, Jane; Main, Barry; Rooshenas, Leila Journal: British journal of surgery Issue: Volume 110:Issue 1(2023) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. (5th March 2019) Authors: Guiraud, Simon; Edwards, Benjamin; Babbs, Arran; Squire, Sarah E; Berg, Adam; Moir, Lee; Wood, Matthew J; Davies, Kay E Journal: Human molecular genetics Issue: Volume 28:Number 13(2019) Page Start: 2189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗